Controlling the Crimson Tide: Intelligent Blood Management (Video)
World's Largest Resource for Cardiovascular Perfusion
Representatives of the transplant community, including recipients and donors, physicians and other healthcare providers, ethicists, lawyers, and scientists, met in June to […]
The aim of the present controlled clinical study was to compare the clinical response of human cultured periosteum (HCP) sheets in combination with platelet-rich plasma (PRP) and porous hydroxyapatite (HA) granules to a mixture of PRP and HA in the treatment of human infrabony periodontal defects.
The presence of diabetes did not modify the effect of a restrictive transfusion strategy on the primary composite outcome, but improved its efficacy on red cell transfusion. Restrictive transfusion triggers are safe and effective in patients with diabetes undergoing cardiac surgery.